Mô hình xu hướng động của mức albumin huyết tương và protein phản ứng C trong khoảng thời gian xung quanh chẩn đoán, tái phát, nhiễm trùng huyết và tử vong của bệnh nhân bạch cầu tủy cấp tính

Estey EH. Acute myeloid leukemia (AML). In: Estey EH, Appelbaum FR, editors. Leukemia and related disorders: integrated treatment approaches, vol. 1. 1st ed. New York: Springer Science+Business Media; 2012. p. 1–36. Short NJ, Rytting ME, Cortes JE. Acute myeloid leukaemia. Lancet. 2018;392(10147):593–606. Stosor V, Zembower TR. Infectious complications in Cancer patients, vol. 1. 1st ed. Switzerland: Springer; 2014. Vincent JL, Beumier M. Diagnostic and prognostic markers in sepsis. Expert Rev Anti-Infect Ther. 2013;11(3):265–75. Wu CW, Wu JY, Chen CK, Huang SL, Hsu SC, Lee MT, et al. Does procalcitonin, C-reactive protein, or interleukin-6 test have a role in the diagnosis of severe infection in patients with febrile neutropenia? A systematic review and meta-analysis. Support Care Cancer. 2015;23(10):2863–72. Mackie PH, Crockson RA, Stuart J. C-reactive protein for rapid diagnosis of infection in leukaemia. J Clin Pathol. 1979;32(12):1253–6. Rose PE, Johnsdon SA, Meakin M, Mackie PH, Stuart J. Serial study of C-reactive protein during infection in leukaemia. J Clin Pathol. 1981;34(3):263–6. Schofield KP, Voulgari F, Gozzard DI, Leyland MJ, Beeching NJ, Stuart J. C-reactive protein concentration as a guide to antibiotic therapy in acute leukaemia. J Clin Pathol. 1982;35(8):866–9. Timonen TT, Koistinen P. C-reactive protein for detection and follow-up of bacterial and fungal infections in severely neutropenic patients with acute leukaemia. Eur J Cancer Clin Oncol. 1985;21(5):557–62. Vladimirova SG, Tarasova LN, Sokol'skaia O, Cherepanova VV. C-reactive protein as a marker of the severity of an infectious process in acute myeloid leukemia patients with neutropenia. Ter Arkh. 2013;85(11):34–40. Vincent JL, Dubois MJ, Navickis RJ, Wilkes MM. Hypoalbuminemia in acute illness: is there a rationale for intervention? A meta-analysis of cohort studies and controlled trials. Ann Surg. 2003;237(3):319–34. Levitt DG, Levitt MD. Human serum albumin homeostasis: a new look at the roles of synthesis, catabolism, renal and gastrointestinal excretion, and the clinical value of serum albumin measurements. Int J Gen Med. 2016;9:229–55. Rothschild MA, Oratz M, Schreiber SS. Serum albumin. Hepatology. 1988;8(2):385–401. Doweiko JP, Nompleggi DJ. The role of albumin in human physiology and pathophysiology, part III: albumin and disease states. JPEN J Parenter Enteral Nutr. 1991;15(4):476–83. Klein S. The myth of serum albumin as a measure of nutritional status. Gastroenterology. 1990;99(6):1845–6. Fuhrman MP. The albumin-nutrition connection: separating myth from fact. Nutrition. 2002;18(2):199–200. Lee JL, Oh ES, Lee RW, Finucane TE. Serum albumin and prealbumin in calorically restricted, nondiseased individuals: a systematic review. Am J Med. 2015;128(9):1023 e1021–2. Soeters PB, Wolfe RR, Shenkin A. Hypoalbuminemia: pathogenesis and clinical significance. JPEN J Parenter Enteral Nutr. 2019;43:181–93. Fleck A, Raines G, Hawker F, Trotter J, Wallace PI, Ledingham IM, et al. Increased vascular permeability: a major cause of hypoalbuminaemia in disease and injury. Lancet. 1985;1(8432):781–4. McCluskey A, Thomas AN, Bowles BJ, Kishen R. The prognostic value of serial measurements of serum albumin concentration in patients admitted to an intensive care unit. Anaesthesia. 1996;51(8):724–7. Hansson LO, Hedlund JU, Ortqvist AB. Sequential changes of inflammatory and nutritional markers in patients with community-acquired pneumonia. Scand J Clin Lab Invest. 1997;57(2):111–8. Blunt MC, Nicholson JP, Park GR. Serum albumin and colloid osmotic pressure in survivors and nonsurvivors of prolonged critical illness. Anaesthesia. 1998;53(8):755–61. Danielski M, Ikizler TA, McMonagle E, Kane JC, Pupim L, Morrow J, et al. Linkage of hypoalbuminemia, inflammation, and oxidative stress in patients receiving maintenance hemodialysis therapy. Am J Kidney Dis. 2003;42(2):286–94. Kaysen GA, Dubin JA, Muller HG, Rosales L, Levin NW, Mitch WE. Inflammation and reduced albumin synthesis associated with stable decline in serum albumin in hemodialysis patients. Kidney Int. 2004;65(4):1408–15. de Mutsert R, Grootendorst DC, Indemans F, Boeschoten EW, Krediet RT, Dekker FW. Association between serum albumin and mortality in dialysis patients is partly explained by inflammation, and not by malnutrition. J Ren Nutr. 2009;19(2):127–35. Zisman DA, Kawut SM, Lederer DJ, Belperio JA, Lynch JP III, Schwarz MI, et al. Serum albumin concentration and waiting list mortality in idiopathic interstitial pneumonia. Chest. 2009;135(4):929–35. Gradel KO, Vinholt PJ, Magnussen B, Pedersen C, Jensen TG, Kolmos HJ, et al. Hypoalbuminaemia as a marker of trans-capillary leakage in community-acquired bacteraemia patients. Epidemiol Infect. 2018;146(5):648–55. Gradel KO, Póvoa P, Vinholt PJ, Magnussen B, Pedersen C, Jensen TG, et al. Real-life data patterns of C-reactive protein and albumin level trajectories around bacteraemia. Biomark Med. 2018;12(11):1251–9. Póvoa P. C-reactive protein: a valuable marker of sepsis. Intensive Care Med. 2002;28(3):235–43. Schmidt M, Pedersen L, Sørensen HT. The Danish civil registration system as a tool in epidemiology. Eur J Epidemiol. 2014;29(8):541–9. Østgard LS, Nørgaard JM, Raaschou-Jensen KK, Pedersen RS, Ronnov-Jessen D, Pedersen PT, et al. The Danish National Acute Leukemia Registry. Clin. Epidemiol. 2016;8:553–60. Vardiman JW, Harris NL, Brunning RD. The World Health Organization (WHO) classification of the myeloid neoplasms. Blood. 2002;100(7):2292–302. Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127(20):2391–405. Østgård LS, Nørgaard JM, Severinsen MT, Sengelov H, Friis L, Jensen MK, et al. Data quality in the Danish National Acute Leukemia Registry: a hematological data resource. Clin. Epidemiol. 2013;5:335–44. Region of Southern Denmark [https://en.wikipedia.org/wiki/Region_of_Southern_Denmark (Accessed 3 Apr 2019)]. Schmidt M, Schmidt SA, Sandegaard JL, Ehrenstein V, Pedersen L, Sørensen HT. The Danish National Patient Registry: a review of content, data quality, and research potential. Clin Epidemiol. 2015;7:449–90. Christiansen JU, Maruard CD, Nielsen HC. LABKA. A real-time computer system for the clinical laboratory. Scand. J. Clin. Lab. Invest. Suppl. 1989;194:57–61. Møller JK. A microcomputer-assisted bacteriology reporting and information system. Acta Pathol Microbiol Immunol Scand B. 1984;92(2):119–26. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–83. Trick WE, Zagorski BM, Tokars JI, Vernon MO, Welbel SF, Wisniewski MF, et al. Computer algorithms to detect bloodstream infections. Emerg Infect Dis. 2004;10(9):1612–20. Team RC. R: a language and environment for statistical computing. In. Vienna: R Foundation for Statistical Computing; 2019. Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, et al. Toxicity and response criteria of the eastern cooperative oncology group. Am J Clin Oncol. 1982;5(6):649–55. Franch-Arcas G. The meaning of hypoalbuminaemia in clinical practice. Clin Nutr. 2001;20(3):265–9. McMillan DC. The systemic inflammation-based Glasgow prognostic score: a decade of experience in patients with cancer. Cancer Treat Rev. 2013;39(5):534–40. Xu HJ, Ma Y, Deng F, Ju WB, Sun XY, Wang H. The prognostic value of C-reactive protein/albumin ratio in human malignancies: an updated meta-analysis. Onco Targets Ther. 2017;10:3059–70. Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet. 2001;357(9255):539–45. Dvorak HF. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. NEJM. 1986;315(26):1650–9. Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420(6917):860–7. Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature. 2008;454(7203):436–44. Heikkila K, Ebrahim S, Lawlor DA. A systematic review of the association between circulating concentrations of C reactive protein and cancer. J Epidemiol Community Health. 2007;61(9):824–33. Gray S, Axelsson B. The prevalence of deranged C-reactive protein and albumin in patients with incurable cancer approaching death. PLoS One. 2018;13(3):e0193693. Reid VL, McDonald R, Nwosu AC, Mason SR, Probert C, Ellershaw JE, et al. A systematically structured review of biomarkers of dying in cancer patients in the last months of life; an exploration of the biology of dying. PLoS One. 2017;12(4):e0175123. Gradel KO, Nielsen SL, Pedersen C, Knudsen JD, Østergaard C, Arpi M, et al. Low completeness of Bacteraemia registration in the Danish National Patient Registry. PLoS One. 2015;10(6):e0131682.